These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Lower levels of whole blood serotonin in obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive symptoms. Ma N; Tan LW; Wang Q; Li ZX; Li LJ Psychiatry Res; 2007 Feb; 150(1):61-9. PubMed ID: 17291595 [TBL] [Abstract][Full Text] [Related]
24. Neopterin levels and dexamethasone suppression test in obsessive-compulsive disorder. Kuloğlu M; Atmaca M; Onal S; Geçici O; Bulut V; Tezcan E Psychiatry Res; 2007 Jun; 151(3):265-70. PubMed ID: 17467061 [TBL] [Abstract][Full Text] [Related]
25. Sensitivity of self-beliefs in obsessive compulsive disorder. Doron G; Moulding R; Kyrios M; Nedeljkovic M Depress Anxiety; 2008; 25(10):874-84. PubMed ID: 18033729 [TBL] [Abstract][Full Text] [Related]
26. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome. Gaab J; Rohleder N; Heitz V; Engert V; Schad T; Schürmeyer TH; Ehlert U Psychoneuroendocrinology; 2005 Feb; 30(2):188-98. PubMed ID: 15471616 [TBL] [Abstract][Full Text] [Related]
27. Sex differences in the phenotypic expression of obsessive-compulsive disorder: an exploratory study from Brazil. Torresan RC; Ramos-Cerqueira AT; de Mathis MA; Diniz JB; Ferrão YA; Miguel EC; Torres AR Compr Psychiatry; 2009; 50(1):63-9. PubMed ID: 19059516 [TBL] [Abstract][Full Text] [Related]
28. Ex vivo lipopolysaccharide (LPS)-induced TNF-alpha, IL-1beta, IL-6 and PGE2 secretion in whole blood from Type 1 diabetes mellitus patients with or without aggressive periodontitis. Araya AV; Pavez V; Perez C; Gonzalez F; Columbo A; Aguirre A; Schiattino I; Aguillón JC Eur Cytokine Netw; 2003; 14(3):128-33. PubMed ID: 14656685 [TBL] [Abstract][Full Text] [Related]
29. Comorbidity of obsessive-compulsive disorder with obsessive-compulsive personality disorder: Does it imply a specific subtype of obsessive-compulsive disorder? Garyfallos G; Katsigiannopoulos K; Adamopoulou A; Papazisis G; Karastergiou A; Bozikas VP Psychiatry Res; 2010 May; 177(1-2):156-60. PubMed ID: 20163876 [TBL] [Abstract][Full Text] [Related]
31. [Comparison of patients with schizophrenia, obsessive-compulsive disorder, and schizophrenia with accompanying obsessive-compulsive symptoms]. Güleç G; Güneş E; Yenilmez C Turk Psikiyatri Derg; 2008; 19(3):247-56. PubMed ID: 18791877 [TBL] [Abstract][Full Text] [Related]
32. An investigation of self-ambivalence in obsessive-compulsive disorder. Bhar SS; Kyrios M Behav Res Ther; 2007 Aug; 45(8):1845-57. PubMed ID: 17408590 [TBL] [Abstract][Full Text] [Related]
33. [A family study of obsessive-compulsive disorder]. Yang Y; Liu X Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Oct; 15(5):303-6. PubMed ID: 9758880 [TBL] [Abstract][Full Text] [Related]
34. Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder. Rodríguez N; Morer A; González-Navarro EA; Serra-Pages C; Boloc D; Torres T; García-Cerro S; Mas S; Gassó P; Lázaro L J Neuroinflammation; 2017 Dec; 14(1):261. PubMed ID: 29284508 [TBL] [Abstract][Full Text] [Related]
35. Enhanced glucocorticoid sensitivity of cytokine release from circulating leukocytes stimulated with lipopolysaccharide in healthy male smokers. Wirtz PH; von Känel R; Kunz-Ebrecht S; Ehlert U; Fischer JE Brain Behav Immun; 2004 Nov; 18(6):536-43. PubMed ID: 15331124 [TBL] [Abstract][Full Text] [Related]
36. Hippocampus and amygdalar volumes in patients with refractory obsessive-compulsive disorder. Atmaca M; Yildirim H; Ozdemir H; Ozler S; Kara B; Ozler Z; Kanmaz E; Mermi O; Tezcan E Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1283-6. PubMed ID: 18485556 [TBL] [Abstract][Full Text] [Related]
37. Inferential confusion in obsessive-compulsive disorder: the inferential confusion questionnaire. Aardema F; O'Connor KP; Emmelkamp PM; Marchand A; Todorov C Behav Res Ther; 2005 Mar; 43(3):293-308. PubMed ID: 15680927 [TBL] [Abstract][Full Text] [Related]
38. Plasma levels of tumor necrosis factor-alpha and interleukin-6 in obsessive compulsive disorder. Konuk N; Tekin IO; Ozturk U; Atik L; Atasoy N; Bektas S; Erdogan A Mediators Inflamm; 2007; 2007():65704. PubMed ID: 17497035 [TBL] [Abstract][Full Text] [Related]
39. [A comparative study of N400 in generalized anxiety disorder versus obsessive compulsive disorder patients]. Zhang C; Chen XS; Ren QS; Yi ZH; Chen C; Fang YR Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(35):2468-72. PubMed ID: 23158711 [TBL] [Abstract][Full Text] [Related]